DiscoverBecker Private Equity & Business PodcastUsing AI to Power Custom Treatments for Rare Diseases with Steven Ringel of Nome Therapeutics 11-10-25
Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel of Nome Therapeutics 11-10-25

Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel of Nome Therapeutics 11-10-25

Update: 2025-11-10
Share

Description

In this episode, Steven Ringel, CEO of the Kazuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients. 

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel of Nome Therapeutics 11-10-25

Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel of Nome Therapeutics 11-10-25

Jeremy Corr